000 | 01772 a2200493 4500 | ||
---|---|---|---|
005 | 20250517115113.0 | ||
264 | 0 | _c20170815 | |
008 | 201708s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0162912 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCuadrado, Irene | |
245 | 0 | 0 |
_aNitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes. _h[electronic resource] |
260 |
_bPloS one _c2016 |
||
300 |
_ae0162912 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBasigin _xmetabolism |
650 | 0 | 4 |
_aCaveolin 3 _xgenetics |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aExtracellular Matrix _xdrug effects |
650 | 0 | 4 |
_aGlycosylation _xdrug effects |
650 | 0 | 4 |
_aHydrazines _xadministration & dosage |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMicroscopy, Confocal |
650 | 0 | 4 |
_aMultiprotein Complexes _xmetabolism |
650 | 0 | 4 |
_aMyocardial Infarction _xgenetics |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xgenetics |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Donors _xadministration & dosage |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
700 | 1 | _aCastejon, Borja | |
700 | 1 | _aMartin, Ana M | |
700 | 1 | _aSaura, Marta | |
700 | 1 | _aReventun-Torralba, Paula | |
700 | 1 | _aZamorano, Jose Luis | |
700 | 1 | _aZaragoza, Carlos | |
773 | 0 |
_tPloS one _gvol. 11 _gno. 9 _gp. e0162912 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0162912 _zAvailable from publisher's website |
999 |
_c26436158 _d26436158 |